Redirecting Ru(II)-Complex into Live-Cell Nucleus for Enantioselective DNA-Imaging and Photosensitizing Via Simple Yin-Yang Ion-Pairing

Ben-Zhan Zhu,Xi-Juan Chao
DOI: https://doi.org/10.1016/j.freeradbiomed.2016.10.087
IF: 8.101
2016-01-01
Free Radical Biology and Medicine
Abstract:Targeted delivery of diagnostic-probes and therapeutics into specific compartments inside a cell is of utmost importance in the improvement of disease detection and treatment. The molecular DNA “light-switch” Ru(II)-polypyridyl complex [Ru(DIP)2(dppz)]2+ has been shown to be accumulated only in the cytoplasm and membrane, but excluded from its intended nuclear DNA target. Here we show that chlorophenolate and flufenamate drugs can redirect [Ru(DIP)2(dppz)]2+ into live-cell nucleus while maintaining its original DNA recognition characteristics, where it acts as an unparalleled nuclear DNA imaging agent which is enantioselective, resistant to photo-bleaching, and suitable for both luminescent and transmission electron microscopy. The underlying molecular mechanism for the preferential nuclear uptake was found to be due to formating a neutral and relatively strong ion-pair between the Ru(II) cationic complex and chlorophenolate or flufenamate counter-anion, which may help the Ru(II) complex escape cytoplasmic traps, and cross the nuclear membrane via passive diffusion. More interestingly, enantioselective apoptosis was induced for cells pretreated with [Ru(DIP)2(dppz)]2+/chlorophenol (or flufenamic acid) upon prolonged visible-light irradiation. We suggest that this novel ion-pairing method and concept can be employed to deliver other similar cationic and bioactive metal complexes with promising theranostic potentials to their preferred intracellular targets.
What problem does this paper attempt to address?